Research and Innovation
Competing Risks in Cardiovascular Research
An educational guide to competing Risks in Cardiovascular Research, focused on research literacy rather than hype.
Big idea in one paragraph
Older adults with cardiovascular disease face multiple failure modes: sudden arrhythmic death, progressive pump failure, cancer, infection.
When one event removes a patient from risk for another, classic survival analysis misstates cumulative incidence.
Research must specify whether the estimand is ‘risk of HF hospitalization in the presence of competing death’ or ‘among those alive.’
Literacy prevents misreading HF trial curves in geriatric populations.
Key methods learners should recognize
Cohort studies of AF ablation vs drugs use competing-risk models for stroke vs death.
Trials with mortality components sometimes publish sensitivity analyses with Fine-Gray methods.
Registry studies of LVAD and transplant list mortality inherently competitive-multiple absorbing states.
Simulation papers teach when bias from ignoring competing risks matters most.
Landmark findings and honest limitations
A relative increase in HF hospitalization subdistribution hazard may reflect reduced competing mortality from treatment-paradoxical interpretation lesson.
Absolute cumulative incidence functions (Aalen-Johansen) should accompany curves-not only cause-specific Cox.
Check censoring: loss to follow-up treated as independent censoring may fail if related to health.
Composite endpoints mixing death and hospitalization still need competing-risk thinking at analysis stage.
Translation barriers
Guideline writers increasingly consult statisticians on competing risks for HF in older adults-methods influence recommendation strength indirectly.
Clinic impact indirect: better trial reporting improves applicability counseling.
Software defaults (standard Cox) still common-reader vigilance required.
Emerging standardization in journal statistical guidelines.
Questions that remain open
Reproduce a simple competing-risk example with published supplemental data if available.
Read AHA statistical methods primers on competing risks.
PubMed ‘competing risks heart failure hospitalization’.
Journal club: which estimand matches patient question?
Putting it together
Competing risks remind us cardiovascular endpoints live in multi-morbid lives-methods must match that reality.
Absolute cumulative incidence beats naive curve reading.
Cardily teaches analysis literacy, not biostatistics licensing.
Educational disclaimer
This article is part of Cardily’s educational Insights library. Cardily content is for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional for personal medical concerns. In an emergency, call local emergency services.